217 related articles for article (PubMed ID: 31804289)
1. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Sirak TE; Jelic S; Le Jemtel TH
J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
5. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
[TBL] [Abstract][Full Text] [Related]
6. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
7. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
8. Heart failure and chronic obstructive pulmonary disease the quandary of Beta-blockers and Beta-agonists.
Hawkins NM; Petrie MC; Macdonald MR; Jhund PS; Fabbri LM; Wikstrand J; McMurray JJ
J Am Coll Cardiol; 2011 May; 57(21):2127-38. PubMed ID: 21596228
[TBL] [Abstract][Full Text] [Related]
9. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
Karoli NA; Rebrov AP
Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
[TBL] [Abstract][Full Text] [Related]
10. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
[TBL] [Abstract][Full Text] [Related]
11. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
Glaab T; Weiss T
Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
[TBL] [Abstract][Full Text] [Related]
12. Beta-blockers use in patients with chronic obstructive pulmonary disease and concomitant cardiovascular conditions.
Albouaini K; Andron M; Alahmar A; Egred M
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):535-40. PubMed ID: 18268926
[TBL] [Abstract][Full Text] [Related]
13. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
14. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
[TBL] [Abstract][Full Text] [Related]
15. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
16. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
Rasmussen DB; Lange P; Jensen MT
Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
[TBL] [Abstract][Full Text] [Related]
17. Impact of beta-blocker use on the long-term outcomes of heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Tay WT; Teng TK; Asai K; Noda T; Kusano K; Suzuki A; Hagiwara N; Hisatake S; Ikeda T; Yasuoka R; Kurita T; Shimizu W;
ESC Heart Fail; 2021 Oct; 8(5):3791-3799. PubMed ID: 34189870
[TBL] [Abstract][Full Text] [Related]
18. Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.
Andrus MR; Loyed JV
Drugs Aging; 2008; 25(2):131-44. PubMed ID: 18257600
[TBL] [Abstract][Full Text] [Related]
19. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003566. PubMed ID: 16235327
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers in COPD: time for reappraisal.
Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
